A New Multiomic Framework Illuminates Alzheimer’s Genetic Roots
A novel analytical framework, PRISM-xQTL, is refining our understanding of Alzheimer’s disease (AD) genetics. The tool integrates pleiotropy, co-localization, and mediation analyses across multiple types of genomic data—including expression, methylation, and splicing—to pinpoint causal genes from noncoding risk variants. The research identified over 400 significant genetic associations across tissues, with a particular focus on the immune-related gene FCER1G. The findings suggest that dysregulated immune signaling, driven by specific genetic variants, is a key mechanism in AD pathogenesis, offering a more precise map for therapeutic targeting.
Why it might matter to you: This research directly addresses the core challenge of interpreting noncoding genetic variants in neurodegeneration, a central puzzle in modern neurology. For professionals focused on Alzheimer’s disease, the PRISM-xQTL framework provides a powerful, systematic method to move from statistical association to causal biology, prioritizing high-confidence targets like FCER1G for drug development. It underscores the critical role of neuroinflammation and immune dysregulation, potentially guiding more effective, mechanism-driven clinical trials.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
